Dr. James Stefater, MD, PHD
What this data tells you about Dr. Stefater
Dr. James Stefater is a retina specialist physician in East Weymouth, MA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Stefater performed 11,192 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Stefater received a total of $14,187 from 13 pharmaceutical and/or device companies across 27 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Stefater is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary — 2023
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
3,600 | $29 | $100 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
1,965 | $34 | $161 |
| Aflibercept eye injection (Eylea) | 1,211 | $690 | $2,500 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
1,090 | $106 | $932 |
| Injection, ranibizumab, 0.1 mg | 982 | $185 | $840 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
803 | $101 | $400 |
| Ranibizumab-nuna biosimilar injection, 0.1 mg An injection of the biosimilar medication ranibizumab-nuna (Byooviz) at a dose of 0.1 mg. |
710 | $157 | $800 |
| Bevacizumab injection, 10 mg Administration of a 10 mg dose of bevacizumab medication via injection. |
311 | $55 | $102 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
309 | $74 | $275 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $119 | $700 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
42 | $19 | $95 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $76 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $106 | $320 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
16 | $14 | $95 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
14 | $43 | $350 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
11 | $550 | $4,125 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
All-time payments by company (2018-2023) ›
Associated products mentioned in payments ›
Geographic Context
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Stefater is a mixed practice specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Stefater experienced with eye injection (vabysmo/faricimab)?
Does Dr. Stefater receive payments from pharmaceutical companies?
How do Dr. Stefater's costs compare to other retina specialist physicians in East Weymouth?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology